Concepedia

Publication | Closed Access

An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma

55

Citations

22

References

2011

Year

Abstract

An ADC targeting the EDNBR is highly efficacious in preclinical models of melanoma.

References

YearCitations

Page 1